Medicine and Dentistry
Therapeutic Procedure
100%
Alteplase
93%
Brain Ischemia
93%
Prourokinase
93%
Urokinase
93%
Mutant
93%
Fibrinolytic Therapy
93%
Cerebral Hemorrhage
81%
Patient
70%
Decision Making
46%
Randomized Clinical Trial
46%
Diagnostic Imaging
46%
Phase II Trials
46%
Analysis
46%
Bleeding
40%
Thrombolytic Drug
35%
Magnetic Resonance Angiography
31%
Computed Tomography Angiography
31%
Apoplexy
25%
Fibrinogen
25%
Follow up
20%
Evaluation Study
20%
Inpatient
19%
Pons
15%
Basal Ganglia
15%
Cerebellum
15%
Thalamus
15%
Diagnosis
15%
Base
15%
Consensus
15%
Neuroradiology
15%
Pathology
15%
Awareness
15%
Hypertension
15%
Cooperation
15%
Odds Ratio
10%
Intention-to-Treat Analysis
10%
Fibrin
9%
Intravenous Drug Administration
9%
Modified Rankin Scale
9%
National Institutes of Health Stroke Scale
9%
Neuroimaging
9%
Consent
9%
Plasma
5%
Depletion
5%
Combination Therapy
5%
Male
5%
Age
5%
Adult
5%
Prognostic Factor
5%
Neuroscience
Ischemic Stroke
46%
Prourokinase
46%
Decision-Making
46%
Alteplase
46%
Urokinase
46%
Intracerebral Hemorrhage
46%
Magnetic Resonance Angiography
31%
Angiography
31%
Stroke
27%
Fibrinogen
23%
Intracranial Hemorrhage
23%
Intention
11%
Fibrin
5%
Pharmacology, Toxicology and Pharmaceutical Science
Alteplase
93%
Brain Ischemia
93%
Fibrinolytic Agent
93%
Urokinase
46%
Brain Hemorrhage
37%
Fibrinogen
28%
Rankin Scale
10%
Fibrin
10%
Bleeding
9%